Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect.
Gao M; Nettles RE; Belema M; Snyder LB; Nguyen VN; Fridell RA; Serrano-Wu MH; Langley DR; Sun JH; O'Boyle DR 2nd; Lemm JA; Wang C; Knipe JO; Chien C; Colonno RJ; Grasela DM; Meanwell NA; Hamann LG; Nature, 2010, vol. 465, issue 7294, p 96, ISSN 14764687. ISBN 14764687.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef